JPWO2022009698A1 - - Google Patents

Info

Publication number
JPWO2022009698A1
JPWO2022009698A1 JP2022535021A JP2022535021A JPWO2022009698A1 JP WO2022009698 A1 JPWO2022009698 A1 JP WO2022009698A1 JP 2022535021 A JP2022535021 A JP 2022535021A JP 2022535021 A JP2022535021 A JP 2022535021A JP WO2022009698 A1 JPWO2022009698 A1 JP WO2022009698A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022535021A
Other languages
Japanese (ja)
Other versions
JPWO2022009698A5 (enExample
JP7740715B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022009698A1 publication Critical patent/JPWO2022009698A1/ja
Publication of JPWO2022009698A5 publication Critical patent/JPWO2022009698A5/ja
Application granted granted Critical
Publication of JP7740715B2 publication Critical patent/JP7740715B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2022535021A 2020-07-06 2021-06-25 ペプチドおよびそれを含む複合体 Active JP7740715B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020116583 2020-07-06
JP2020116583 2020-07-06
PCT/JP2021/024125 WO2022009698A1 (ja) 2020-07-06 2021-06-25 ペプチドおよびそれを含む複合体

Publications (3)

Publication Number Publication Date
JPWO2022009698A1 true JPWO2022009698A1 (enExample) 2022-01-13
JPWO2022009698A5 JPWO2022009698A5 (enExample) 2024-07-02
JP7740715B2 JP7740715B2 (ja) 2025-09-17

Family

ID=79553070

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022535021A Active JP7740715B2 (ja) 2020-07-06 2021-06-25 ペプチドおよびそれを含む複合体

Country Status (2)

Country Link
JP (1) JP7740715B2 (enExample)
WO (1) WO2022009698A1 (enExample)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009539357A (ja) * 2006-06-06 2009-11-19 ヘルムホルツ−ツェントルム フュア インフェクツィオンスフォルシュンク ゲーエムベーハー リウマチ熱関連ペプチド（ｐａｒｆ）および診断マーカーとしてのその使用
WO2014119753A1 (ja) * 2013-01-31 2014-08-07 学校法人 東京薬科大学 マイオスタチン阻害ペプチド
JP2016523274A (ja) * 2013-06-26 2016-08-08 ザイジェン インフラメーション リミテッド 種々の疾患を処置するためのｊｎｋシグナル伝達経路の新規の細胞透過性ペプチド阻害剤の使用
JP2017528417A (ja) * 2014-06-12 2017-09-28 ザ ユニヴァーシティ オブ バース 薬物送達強化剤
WO2018030432A1 (ja) * 2016-08-10 2018-02-15 学校法人東京薬科大学 ペプチドもしくはその薬学的に許容される塩、またはそれらのプロドラッグ
JP2020059663A (ja) * 2018-10-09 2020-04-16 学校法人東京薬科大学 ペプチドもしくはその薬学的に許容される塩、またはそれらのプロドラッグ

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009539357A (ja) * 2006-06-06 2009-11-19 ヘルムホルツ−ツェントルム フュア インフェクツィオンスフォルシュンク ゲーエムベーハー リウマチ熱関連ペプチド（ｐａｒｆ）および診断マーカーとしてのその使用
WO2014119753A1 (ja) * 2013-01-31 2014-08-07 学校法人 東京薬科大学 マイオスタチン阻害ペプチド
JP2016523274A (ja) * 2013-06-26 2016-08-08 ザイジェン インフラメーション リミテッド 種々の疾患を処置するためのｊｎｋシグナル伝達経路の新規の細胞透過性ペプチド阻害剤の使用
JP2017528417A (ja) * 2014-06-12 2017-09-28 ザ ユニヴァーシティ オブ バース 薬物送達強化剤
WO2018030432A1 (ja) * 2016-08-10 2018-02-15 学校法人東京薬科大学 ペプチドもしくはその薬学的に許容される塩、またはそれらのプロドラッグ
JP2020059663A (ja) * 2018-10-09 2020-04-16 学校法人東京薬科大学 ペプチドもしくはその薬学的に許容される塩、またはそれらのプロドラッグ

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
OKAMOTO, HIDEYUKI ET AL.: "Inactivation of myostatin by photo-oxygenation using catalyst-functionalized peptides", CHEM. COMMUN., vol. 55, JPN7021002903, 2019, pages 9108 - 9111, ISSN: 0005591941 *
TAKAYAMA, KENTARO ET AL.: "Chain-Shortened Myostatin Inhibitory Peptides Improve Grip Strength in Mice", ACS MED. CHEM. LETT., vol. 10, JPN6021029705, 2019, pages 985 - 990, ISSN: 0005591942 *

Also Published As

Publication number Publication date
WO2022009698A1 (ja) 2022-01-13
JP7740715B2 (ja) 2025-09-17

Similar Documents

Publication Publication Date Title
BR112023005462A2 (enExample)
BR112023012656A2 (enExample)
BR112021014123A2 (enExample)
BR112023009656A2 (enExample)
BR112022009896A2 (enExample)
BR112023008622A2 (enExample)
BR112022024743A2 (enExample)
BR112022026905A2 (enExample)
BR112023011738A2 (enExample)
BR112023004146A2 (enExample)
BR112023006729A2 (enExample)
BR102021018859A2 (enExample)
BR102021015500A2 (enExample)
BR112021017747A2 (enExample)
BR112023016292A2 (enExample)
BR112023011610A2 (enExample)
BR112023011539A2 (enExample)
BR112023008976A2 (enExample)
BR102021020147A2 (enExample)
BR102021018926A2 (enExample)
BR102021018167A2 (enExample)
BR102021017576A2 (enExample)
BR102021016837A2 (enExample)
BR102021016551A2 (enExample)
BR102021016375A2 (enExample)

Legal Events

Date Code Title Description
A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A5211

Effective date: 20221213

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230111

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240624

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240624

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250513

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250709

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250805

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250828

R150 Certificate of patent or registration of utility model

Ref document number: 7740715

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150